Joel Smith
Senior Researcher
Joel joined HERC in September 2015 as a Senior Researcher to lead, promote and co-ordinate economic activity within the Oxford Biomedical Research Centre. His research interests include the microeconometric analysis of health data and heterogeneous treatment effects. Joel joins HERC from the University of Edinburgh where his research portfolio has been supported by the Economic and Social Research Council (ESRC), National Institute for Health Research: Health Technology Assessment (NIHR HTA) and the Chief Scientist Office (CSO).
Recent publications
-
Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus.
Bolton C. et al, (2020), Drugs R D
-
Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial
Coonan A. et al, (2020), PLOS ONE, 15, e0231241 - e0231241
-
A Systematic Review of Health Economic Evaluations of Proton Beam Therapy for Adult Cancer: Appraising Methodology and Quality
JONES D. et al, (2019), Clinical and Translational Radiation Oncology
-
Correction: A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres.
Smith JBE. et al, (2019), PloS one, 14, e0216315 - e0216315
-
Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2-a study protocol.
Norman JE. et al, (2018), BMJ Open, 8